adr_usa_0488|MREO|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
adr_usa_0488|MREO|Long Name|1|1|Mereo BioPharma Group PLC Total Current Assets (Quarterly) (USD)|Mereo BioPharma Group PLC Cash and Short Term Investments (Quarterly) (USD)|Mereo BioPharma Group PLC Inventories (Quarterly) (USD)|Mereo BioPharma Group PLC Net PP&E (Quarterly) (USD)|Mereo BioPharma Group PLC Goodwill and Intangibles (Quarterly) (USD)|Mereo BioPharma Group PLC Total Liabilities (Quarterly) (USD)|Mereo BioPharma Group PLC Total Current Liabilities (Quarterly) (USD)|Mereo BioPharma Group PLC Total Long Term Liabilities (Quarterly) (USD)|Mereo BioPharma Group PLC Total Deposits (Quarterly) (USD)|Mereo BioPharma Group PLC Book Value (Quarterly) (USD)|Mereo BioPharma Group PLC Retained Earnings (Quarterly) (USD)|Mereo BioPharma Group PLC Treasury Stock (Quarterly) (USD)|Mereo BioPharma Group PLC EV to Revenues|Mereo BioPharma Group PLC EV to Earnings|Mereo BioPharma Group PLC EV to Free Cash Flow|Mereo BioPharma Group PLC EV to Assets (Quarterly)|Mereo BioPharma Group PLC PS Ratio|Mereo BioPharma Group PLC PE Ratio|Mereo BioPharma Group PLC Price to Book Value|Mereo BioPharma Group PLC PEG Ratio|Mereo BioPharma Group PLC Debt to Equity Ratio|Mereo BioPharma Group PLC Dividend Yield|Mereo BioPharma Group PLC Shareholder Yield (TTM)|Mereo BioPharma Group PLC Percent of Shares Outstanding Short|Mereo BioPharma Group PLC Total Receivables (Quarterly) (USD)|Mereo BioPharma Group PLC Total Payables (Quarterly) (USD)|Mereo BioPharma Group PLC Total Capital Stock (Quarterly) (USD)|Mereo BioPharma Group PLC Return on Invested Capital|Mereo BioPharma Group PLC Quality Ratio Score|Mereo BioPharma Group PLC Momentum Score|Mereo BioPharma Group PLC Beta (1Y)|Mereo BioPharma Group PLC Sustainable Growth Rate (TTM)|Mereo BioPharma Group PLC Institutional Investor Ownership Percentage|Mereo BioPharma Group PLC Average Diluted Shares Outstanding (Quarterly)|Mereo BioPharma Group PLC Total Employees (Annual)|Mereo BioPharma Group PLC EPS Diluted (Quarterly) (USD)|Mereo BioPharma Group PLC Shares Outstanding|Mereo BioPharma Group PLC Repurchase of Capital Stock (Quarterly) (USD)|Mereo BioPharma Group PLC Ordinary Shares Number (Quarterly)|Mereo BioPharma Group PLC Payout Ratio|Mereo BioPharma Group PLC Quick Ratio (Quarterly)|Mereo BioPharma Group PLC Normalized Diluted EPS (Quarterly) (USD)|Mereo BioPharma Group PLC Stock Buybacks (Quarterly) (USD)|Mereo BioPharma Group PLC Effective Tax Rate (TTM)|Mereo BioPharma Group PLC Return on Equity|Mereo BioPharma Group PLC Net Income (TTM) (USD)|Mereo BioPharma Group PLC Revenue (TTM) (USD)|Mereo BioPharma Group PLC Dividend Per Share (Quarterly) (USD)|Mereo BioPharma Group PLC Revenue (Quarterly) (USD)|Mereo BioPharma Group PLC Gross Profit (Quarterly) (USD)|Mereo BioPharma Group PLC SG&A Expense (Quarterly) (USD)|Mereo BioPharma Group PLC Pre-Tax Income (Quarterly) (USD)|Mereo BioPharma Group PLC Net Income (Quarterly) (USD)|Mereo BioPharma Group PLC Net Interest Income (Quarterly) (USD)|Mereo BioPharma Group PLC Price (USD)|Mereo BioPharma Group PLC Total Return Price (USD)|Mereo BioPharma Group PLC Enterprise Value (USD)|Mereo BioPharma Group PLC 30-Day Average Daily Volume|Mereo BioPharma Group PLC 1 Year Price Returns (Daily)
adr_usa_0488|MREO|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
adr_usa_0488|MREO||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
adr_usa_0488|MREO||5|5|182.545454545|182.545454545|0|182.545454545|182.545454545|182.545454545|182.545454545|182.545454545|0|182.545454545|182.545454545|182.428571429|0|0|6.92156862745|0|0|0|6.96710526316|0|0|1.44672131148|0|15.2205882353|182.545454545|182.545454545|182.545454545|0|0|31.9|30.4090909091|0|0|0|365.5|0|60.8333333333|0|182.545454545|0|0|0|0|182.6|0|182.6|0|0|0|0|0|0|0|0|6.96710526316|6.96710526316|6.96710526316|6.96575342466|1.44676409186
adr_usa_0488|MREO||6|6|11|11|0|11|11|11|11|11|0|11|11|7|0|0|153|0|0|0|152|0|0|732|0|68|11|11|11|0|0|20|22|0|0|0|2|0|24|0|11|0|0|0|0|10|0|10|0|0|0|0|0|0|0|0|152|152|152|146|479
adr_usa_0488|MREO||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
adr_usa_0488|MREO|201512|201512|201512|20.5108|18.1454||0.303|38.2419|6.102|5.8927|0.2094||52.9536|-18.0579||||||||||||||1.5546|2.0578|0.0877||||||||||||71.095||||||||||||||||||||
adr_usa_0488|MREO|201606|201606|201606|100.6374|94.471||0.2547|34.7486|13.293|7.8277|5.4652||122.3477|-26.8095||||||||||||||5.1576|7.8277|0.2598|||||||||||||||||12.8473||-21.1536|||||||||||||
adr_usa_0488|MREO|201612|201612|201612|74.6664|65.8206||0.2136|31.7115|9.2237|3.9424|5.2813||97.3677|-49.852||||||||||||||7.127|1.3773|0.2371|||||||||||||||||15.5944||-38.1263|||||||||||||
adr_usa_0488|MREO|201706|201706|201706|82.933|73.6058||0.2189|33.5832|20.4126|15.5211|4.8915||96.3224|-73.1943||||||||||||||6.5451|15.5211|0.2756|||||||||||||||||17.4548||-46.0449|||||||||||||
adr_usa_0488|MREO|201712|201712|201712|85.3772|71.0089||0.2073|44.6033|45.7476|12.9972|32.7503||84.4402|-107.1875|0|||||||||||||11.3038|4.0867|0.2882||||||||||||71.095|||||17.3784||-50.3941|||||||||||||
adr_usa_0488|MREO|201801|201712|201712|||||||||||||||||||||||||||||||||||||14.219||||||||||||||||||||||
adr_usa_0488|MREO|201806|201806|201806|64.3758|48.2589||0.1987|42.7389|45.6707|18.4917|27.179||61.6426|-125.7442||||||||||||||14.5144|6.5155|0.279||||||||||||71.1551|||||15.2653||-44.4712|||||||||||||
adr_usa_0488|MREO|201807|201806|201806|||||||||||||||||||||||||||||||||||||14.231||||||||||||||||||||||
adr_usa_0488|MREO|201808|201806|201806|||||||||||||||||||||||||||||||||||||14.2501||||||||||||||||||||||
adr_usa_0488|MREO|201812|201812|201812|43.7707|34.948||0.1891|41.4067|43.7834|20.527|23.2564||41.5831|-141.1283|0.3896|||||||||||||7.097|5.7989|0.2715||||||||31||14.2481||71.2403|||||14.0878||-42.5007|||||||||||||
adr_usa_0488|MREO|201901|201812|201812|||||||||||||||||||||||||||||||||||||14.2481||||||||||||||||||||||
adr_usa_0488|MREO|201904|201903|201903|||||||||||||||-3.7839||||3.002|||0||0.0347|||||||||||||19.2047||||||||||||||||||6.5001|6.5001|117.1467||
adr_usa_0488|MREO|201905|201903|201903|||||||||||||||-2.447||||2.0067|||0||0.0038|||||||||||||||||||||||||||||||4.345|4.345|75.7587||
adr_usa_0488|MREO|201906|201906|201906|61.9502|45.7711||16.6017|57.2262|60.9687|26.6936|34.2751||74.8094|-161.3962|1.6536|||-1.4326||||1.2514|||0||0.0198|12.2907|8.5646|0.3724||||||||||19.5919||97.9596|||||14.6617||-40.2023|||||||||2.7097|2.7097|44.3532|15620.9667|
adr_usa_0488|MREO|201907|201906|201906|||||||||||||||-0.6568||||0.6809|||0||0.0185|||||||||||||||||||||||||||||||2.6|2.6|30.1741|34766.7|
adr_usa_0488|MREO|201908|201906|201906|||||||||||||||-1.1066||||0.9572|||0||0.0509|||||||||||||||||||||||||||||||3.655|3.655|50.8436|18104.4667|
adr_usa_0488|MREO|201909|201909|201909|||||||||||||||-0.8316||||0.7883|||0||0.0132|||||||||||||||||||||||||||||||3.01|3.01|38.2068|11398.7|
adr_usa_0488|MREO|201910|201909|201909|||||||||||||||-0.8913||||0.825|||0||0.0192|||||||||||||||||||||||||||||||3.15|3.15|40.9497|13409.2667|
adr_usa_0488|MREO|201911|201909|201909|||||||||||||||-0.5288||||0.6023|||0||0.005|||||||||||||||||||||||||||||||2.3|2.3|24.2966|10807.9333|
adr_usa_0488|MREO|201912|201912|201912|39.9055|21.4337||15.1545|58.2894|60.5669|39.1751|21.3917||52.7825|-191.516|1.7111|||-0.4649||||1.2175|||0||1.5811|15.3197|8.3286|0.3855||||||||50||19.5919||97.9596|||||15.2608||-44.838|||||||||2.15|2.15|21.3578|307216.4333|
adr_usa_0488|MREO|202001|201912|201912|||||||||||||||-0.6694||||0.657|||0||0.148|||||||||||||||||||||||||||||||1.74|1.74|39.5509|451261.3667|
adr_usa_0488|MREO|202002|201912|201912|||||||||||||||-0.7688||||0.7869|||0||0.1154|||||||||||||22.451||||||||||||||||||1.78|1.78|45.4238|150581.8333|
adr_usa_0488|MREO|202003|202003|202003|||||||||||||||-0.5559||||0.493|||0||0.1377|||||||||||||24.9016||||||||||||||||||1.0636|1.0636|32.8478|95553.8|
adr_usa_0488|MREO|202004|202003|202003|||||||||||||||-0.6698||||0.5661|||0||0.0468|||||||1.3559||||||||||||||||||||||||1.23|1.23|39.5762|71882.0333|-75.5357
adr_usa_0488|MREO|202005|202003|202003|||||||||||||||-0.6192||||0.5944|||0||0.0389||||||1|1.1571||||||||||||||||||||||||1.23|1.23|36.588|102183.9667|-70.771
adr_usa_0488|MREO|202006|202006|202006|82.077|69.9404||13.8167|39.2358|105.2903|27.5325|77.7578||29.8392|-333.1785|1.6063|||-2.262||||6.947|||0||0.6413|10.4133|6.7564|1.2506|||1|2.1623||||||67.7428||338.714|||||3.6445||-178.5281|||||||||3.06|3.06|133.6525|537082.1|21.4286
adr_usa_0488|MREO|202007|202006|202006|||||||||||||||-3.9693||||6.6973|||0||0.6505||||||8|1.8962||||||67.7428||||||||||||||||||2.79|2.79|148.4895|276772.5333|9.6154
adr_usa_0488|MREO|202008|202006|202006|||||||||||||||-4.1504||||6.6746|||0||1.204||||||7|1.9804||||||67.7428||||||||||||||||||2.91|2.91|155.2638|279861.3333|-18.5286
adr_usa_0488|MREO|202009|202009|202009|||||||||||||||-3.8244||||5.7892|||0||1.3969||||||4|2.0825||||||||||||||||||||||||2.62|2.62|143.0701|264615.7|-12.0805
adr_usa_0488|MREO|202010|202009|202009|||||||||||||||-3.4079||||5.6075|||0||1.8259||||||5|2.1624||||||||||||||||||||||||2.38|2.38|127.4893|162505.8667|-24.7619
adr_usa_0488|MREO|202011|202009|202009|||||||||||||||-3.4532||||5.3578|||0||1.7934||||||3|1.8852||||||||||||||||||||||||2.37|2.37|129.1828|130211.5333|2.9536
adr_usa_0488|MREO|202012|202012|202012|40.5115|31.9843||2.1437|43.1308|106.189|11.6726|94.5163||-20.4029|-422.0589|1.7785|||-5.5266||||8.1275|||0||8.3528|5.7661|4.5423|1.386|||6|1.9457||||38||67.7906||338.9531|||||1.7202||-206.0109|||||||||3.55|3.55|206.7483|3920436.1333|9.1463
adr_usa_0488|MREO|202101|202012|202012|||||||||||||||-5.3347|||||||0||10.3131||||||7|1.9192||||||68.5703||||||||||||||||||2.69|2.69|194.7644|4017445.0333|57.2254
adr_usa_0488|MREO|202102|202012|202012|||||||||||||||-11.1305|||||||0||3.4901||||||8|2.3032||||||108.2453||||||||||||||||||4.02|4.02|406.3643|2471591.6333|117.3184
adr_usa_0488|MREO|202103|202103|202103|||||||||||||||-9.6292|||||||0||7.5932||||||8|0.8842||||||||||||||||||||||||3.37|3.37|351.5538|3400422.3|222.488
adr_usa_0488|MREO|202104|202103|202103|||||||||||||||-10.2519|||||||0||7.5435||||||9|0.4146||||||108.2453||||||||||||||||||3.57|3.57|374.2854|1996287.2|159.1241
adr_usa_0488|MREO|202105|202103|202103|||||||||||||||-8.9473|||||||0||8.0297|||||||0.8598||||||||||||||||||||||||3.23|3.23|326.6574|992636.9|161.6
adr_usa_0488|MREO|202106|202106|202106|166.5436|152.3687||3.3078|30.7137|88.9026|13.6628|75.2398||111.6625|-411.8853|1.593|||-24.6477|1.0853|||||0.2223|0||10.2437|8.0576|3.0268|2.2615|||8|1.5543||||||108.9021||544.5103||11.7418|||9.0087||-34.5738|||||||||3.17|3.17|322.3276|1558091|3.5948
adr_usa_0488|MREO|202107|202106|202106|||||||||||||||-17.2489||||2.4284|||0||7.2651||||||3|1.7945||||||||||||||||||||||||2.74|2.74|143.6168|1762709.5|-5.5147
adr_usa_0488|MREO|202108|202106|202106|||||||||||||||-19.8385||||2.721|||0||7.0745||||||2|1.9468||||||||||||||||||||||||2.75|2.75|176.2874|1101389.4667|-6.689
adr_usa_0488|MREO|202109|202109|202109|||||||||||||||-15.2758||||2.4577|||0||6.6399||||||3|1.9256||||||||||||||||||||||||2.4|2.4|146.8839|815661.5667|-7.6336
adr_usa_0488|MREO|202110|202109|202109|||||||||||||||-13.3028||||2.1359|||0||7.6845||||||3|1.4696||||||||||||||||||||||||2.14|2.14|110.9462|882465.2333|-6.639
adr_usa_0488|MREO|202111|202109|202109|||||||||||||||-8.9868||||1.7165|||0||4.8115||||||3|2.7506||||||||||||||||||||||||2.06|2.06|64.1183|861659.1|-27.8689
adr_usa_0488|MREO|202112|202112|202112|||||||||||||||-4.9174||||1.4727|||0||5.4952||||||3|1.803||||||116.9816||||||||||||||||||1.57|1.57|36.8927|1048803.1333|-55.3073
adr_usa_0488|MREO|202201|202112|202112|||||||||||||||0.1369||||1.2676|||0||6.3097||||||2|1.55||||||||||||||||||||||||1.16|1.16|-1.2093|833037.9667|-51.8382
adr_usa_0488|MREO|202202|202112|202112|||||||||||||||-1.85||||1.3829|||0||5.6945||||||2|1.0058||||||||||||||||||||||||1.15|1.15|16.3379|478807.4333|-68.1234
adr_usa_0488|MREO|202203|202203|202203|||||||||||||||-3.1746||||1.3934|||0|||||||||||||||||||||||||||||||||1.33|1.33|28.0361|354529.2|-66.4141